Last reviewed · How we verify
Fluzone vaccine with JVRS-100 adjuvant — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Fluzone vaccine with JVRS-100 adjuvant (Fluzone vaccine with JVRS-100 adjuvant) — Colby Pharmaceutical Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fluzone vaccine with JVRS-100 adjuvant TARGET | Fluzone vaccine with JVRS-100 adjuvant | Colby Pharmaceutical Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fluzone vaccine with JVRS-100 adjuvant CI watch — RSS
- Fluzone vaccine with JVRS-100 adjuvant CI watch — Atom
- Fluzone vaccine with JVRS-100 adjuvant CI watch — JSON
- Fluzone vaccine with JVRS-100 adjuvant alone — RSS
Cite this brief
Drug Landscape (2026). Fluzone vaccine with JVRS-100 adjuvant — Competitive Intelligence Brief. https://druglandscape.com/ci/fluzone-vaccine-with-jvrs-100-adjuvant. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab